| Hometown Pharmacy #51 - Grand Rapid | |
| 4252 Kalamazoo Ave Se, Grand Rapids, Michigan 49508 | |
| (616) 281-1323 |
| Name | Hometown Pharmacy #51 - Grand Rapid |
|---|---|
| Organization Name | Hometown Pharmacy Inc |
| Location | 4252 Kalamazoo Ave Se, Grand Rapids, Michigan 49508 |
| Type | Long Term Care Pharmacy |
| Phone | (616) 281-1323 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Repligen Corporation announced today that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved the Company's proposal to re-analyze the images from our Phase 3 study to establish the utility of RG1068, synthetic human secretin, in improving magnetic resonance imaging (MRI) of the pancreas (Phase 3 re-read).
A team from the University of Valencia, the La Fe Hospital Health Research Institute, and the INCLIVA Institute have participated in the identification of an enzyme (G6PD) as a possible therapeutic target in autoimmune diseases or in controlling exacerbated inflammatory responses such as the one caused by SARS-CoV-2 infection.
More than 90 percent of patients with chronic pain continue to receive prescription opioids after an overdose and are at high risk for experiencing a repeated overdose, according to an article published in Annals of Internal Medicine.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
› Verified 2 days ago
| NPI Number | 1356981922 |
| Organization Name | HOME TOWN PHARMACY INC |
| Type | Long Term Care Pharmacy |
| Address | 4252 Kalamazoo Ave Se, Grand Rapids, MI 49508 |
| Phone Number | 616-281-1323 |
News Archive
Repligen Corporation announced today that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved the Company's proposal to re-analyze the images from our Phase 3 study to establish the utility of RG1068, synthetic human secretin, in improving magnetic resonance imaging (MRI) of the pancreas (Phase 3 re-read).
A team from the University of Valencia, the La Fe Hospital Health Research Institute, and the INCLIVA Institute have participated in the identification of an enzyme (G6PD) as a possible therapeutic target in autoimmune diseases or in controlling exacerbated inflammatory responses such as the one caused by SARS-CoV-2 infection.
More than 90 percent of patients with chronic pain continue to receive prescription opioids after an overdose and are at high risk for experiencing a repeated overdose, according to an article published in Annals of Internal Medicine.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
› Verified 2 days ago
| NPI Number | 1578670410 |
| Organization Name | HOMETOWN PHARMACY INC |
| Doing Business As | HOMETOWN PHARMACY #51 - GRAND RAPIDS |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4252 Kalamazoo Ave Se, Grand Rapids, MI 49508 |
| Phone Number | 616-281-1323 |
News Archive
Repligen Corporation announced today that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved the Company's proposal to re-analyze the images from our Phase 3 study to establish the utility of RG1068, synthetic human secretin, in improving magnetic resonance imaging (MRI) of the pancreas (Phase 3 re-read).
A team from the University of Valencia, the La Fe Hospital Health Research Institute, and the INCLIVA Institute have participated in the identification of an enzyme (G6PD) as a possible therapeutic target in autoimmune diseases or in controlling exacerbated inflammatory responses such as the one caused by SARS-CoV-2 infection.
More than 90 percent of patients with chronic pain continue to receive prescription opioids after an overdose and are at high risk for experiencing a repeated overdose, according to an article published in Annals of Internal Medicine.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
› Verified 2 days ago
News Archive
Repligen Corporation announced today that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved the Company's proposal to re-analyze the images from our Phase 3 study to establish the utility of RG1068, synthetic human secretin, in improving magnetic resonance imaging (MRI) of the pancreas (Phase 3 re-read).
A team from the University of Valencia, the La Fe Hospital Health Research Institute, and the INCLIVA Institute have participated in the identification of an enzyme (G6PD) as a possible therapeutic target in autoimmune diseases or in controlling exacerbated inflammatory responses such as the one caused by SARS-CoV-2 infection.
More than 90 percent of patients with chronic pain continue to receive prescription opioids after an overdose and are at high risk for experiencing a repeated overdose, according to an article published in Annals of Internal Medicine.
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743 ordinary shares in the form of American Depositary Shares in exchange for 4,558 senior debentures (equivalent to USD 4,558,000) and 986,965 warrants, reducing the current outstanding debt by USD 4.6 million to USD 10.5 million.
› Verified 2 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4513 Broadmoor Seave D, Grand Rapids, Michigan 49512 Phone: (616) 698-9119 | |
Careline Medical Equipment & Supply Type: Durable Medical Equipment & Medical Supplies Supplier Location: 89 54th St Sw, Grand Rapids, Michigan 49548 Phone: (616) 249-2273 | |
Cvs Pharmacy #08292 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1155 Fuller Ave Ne, Grand Rapids, Michigan 49503 Phone: (616) 774-1041 | |
Cvs Pharmcy #05610 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3590 Plainfield Ave Ne, Grand Rapids, Michigan 49525 Phone: (616) 447-2563 | |
Cvs Pharmacy #17107 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5120 28th St Se, Grand Rapids, Michigan 49512 Phone: (616) 222-4890 |